4baseCare Raises $6 Million in Series A Funding
Startup Aims to Enhance Precision Medicine for Cancer
Bengaluru, India (August 12, 2024)
4baseCare, a leading provider of precision oncology solutions, announced today that it has secured $6 million in Series A funding. The round was led by Yali Capital, a global healthcare investment firm.
The funding will be used to expand 4baseCare's team, accelerate product development, and enhance its platform for providing personalized cancer care. 4baseCare's innovative solutions leverage sophisticated AI and genomics technologies to deliver tailored treatment recommendations for each patient.
In an increasingly complex healthcare landscape, 4baseCare's cutting-edge solutions empower clinicians with deep insights into cancer biology. The company's mission is to democratize precision medicine, making it accessible to all patients regardless of geography or socioeconomic status.
This latest investment is a testament to the growing demand for personalized cancer care and the potential of 4baseCare's transformative solutions. The funds will fuel the company's mission to create a future where every cancer patient has access to optimal treatment strategies tailored to their unique needs.
Comments